New Brunswick, N.J., United States:
Johnson & Johnson (the “Company”) (NYSE: JNJ) right now took one other step ahead in establishing two unbiased, market-leading firms with the announcement of Kenvue as the title for the deliberate New Consumer Health Company. The new company model involves life by way of a compelling goal, and a timeless visible model.
This press launch options multimedia. View the full launch right here: https://www.businesswire.com/news/home/20220928005340/en/
Kenvue (pronounced ken·view), is impressed by two highly effective concepts: “ken” – that means information, an English phrase primarily utilized in Scotland, and “vue,” referencing sight. With wealthy information of human wants and deep shopper insights, Kenvue will ship significant, private well being options.
“Unveiling the Kenvue brand is a defining moment for our stakeholders and an important part of the planned separation,” mentioned Thibaut Mongon, CEO Designate, Kenvue, the deliberate New Consumer Health Company. “We breathe life into some of the world’s most iconic and beloved brands every day, so we harnessed that same expertise, love, and energy into developing our new corporate identity.”
Kenvue’s goal, Realize the Extraordinary Power of Everyday Care, will information the firm’s actions and long-term aspirations, from technique to expertise philosophy, and extra.
“We believe that daily self-care rituals add up over time and have a profound cumulative impact on your wellbeing. This is the extraordinary power of everyday care. And our work is to put that power into the hands of consumers around the world,” Mongon provides.
Along with the title and goal, Kenvue’s visible identification represents the firm’s timelessness, whereas permitting house for its iconic manufacturers to even have a house. The new emblem facilities on the “K” image, embodying the firm’s strengths – the geometry of the rectangle representing scientific precision and the spherical edges evoking the heat of care. The company title is depicted in a particular logotype in a wealthy inexperienced. This sturdy, distinctive shade works in concord with the multicolored palette of the firm’s portfolio of well-known manufacturers.
Joaquin Duato, Chief Executive Officer of Johnson & Johnson provides, “Today’s announcement is another milestone for the Consumer Health business. Kenvue is poised to thrive as a standalone company with a leading portfolio of brands consumers love and trust. I’m confident in this team and excited to see what the future holds.”
Kenvue Post-Separation: A Leading Global Consumer Health Company with Iconic Brands and Commitment to Continued Innovation
Kenvue will develop into a standalone main world shopper well being firm in 2023, topic to authorized necessities together with session with works councils and worker representatives, as required. Kenvue will proceed to the touch the lives of over one billion shoppers worldwide day-after-day by way of its iconic portfolio of beloved manufacturers such as AVEENO®, BAND-AID® Brand Adhesive Bandages, LISTERINE®, NEUTROGENA®, TYLENOL®, JOHNSON’S® and DR. CI:LABO®, and can proceed its longstanding legacy of innovation.
Usage of the new firm emblem and company model identification shall be efficient upon completion of the deliberate separation. More info concerning Kenvue, together with the firm’s board of administrators and monetary transaction info shall be obtainable at a later date.
The Consumer Health phase generated income of $14.6 billion in Full-Year 2021 and, following the deliberate separation, Kenvue would generate gross sales in over 100 nations, pushed by world-class innovation capabilities and demonstrated business momentum.
In latest years, Johnson & Johnson has centered the Consumer Health business and superior its innovation, enabling it to achieve extra shoppers with merchandise that really make a distinction in peoples’ lives, whereas concurrently increasing margins and delivering wholesome monetary outcomes. These actions have bolstered positions in Self Care, Skin Health and Essential Health.
About Johnson & Johnson
At Johnson & Johnson, we imagine good well being is the basis of vibrant lives, thriving communities and ahead progress. That’s why for greater than 135 years, we have now aimed to maintain folks nicely at all ages and each stage of life. Today, as the world’s largest and most broadly-based healthcare firm, we’re dedicated to utilizing our attain and measurement for good. We attempt to enhance entry and affordability, create more healthy communities, and put a wholesome thoughts, physique and atmosphere inside attain of everybody, in every single place. We are mixing our coronary heart, science and ingenuity to profoundly change the trajectory of well being for humanity. Learn extra at www.jnj.com. Follow us at @JNJNews.
Cautions Concerning Forward-Looking Statements
This launch comprises “forward-looking statements” as outlined in the Private Securities Litigation Reform Act of 1995 concerning, amongst different issues: the anticipated separation of Johnson & Johnson’s Consumer Health business; future working and monetary efficiency, product improvement, market place and business technique. Readers are cautioned to not depend on these forward-looking statements. These statements are primarily based on present expectations of future occasions. If underlying assumptions show inaccurate or identified or unknown dangers or uncertainties materialize, precise outcomes might differ materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties embrace, however should not restricted to: Johnson & Johnson’s potential to fulfill the vital situations to consummate the separation of Johnson & Johnson’s Consumer Health business on a well timed foundation or in any respect; Johnson & Johnson’s potential to efficiently separate Johnson & Johnson’s Consumer Health business and understand the anticipated advantages from the separation; the New Consumer Health Company’s potential to succeed as a standalone publicly traded firm; financial components, such as rate of interest and foreign money change price fluctuations; competitors, together with technological advances, new merchandise and patents attained by rivals; challenges inherent in new product analysis and improvement, together with surprising medical trial outcomes, extra evaluation of present medical information, uncertainty of medical success and acquiring regulatory approvals; uncertainty of economic success for new and present merchandise; the affect of business combos and divestitures; challenges to patents; the affect of patent expirations; the potential of Johnson & Johnson to efficiently execute strategic plans, together with restructuring plans; manufacturing difficulties or delays, internally or inside the provide chain; product efficacy or security considerations leading to product recollects or regulatory motion; important opposed litigation or authorities motion, together with associated to product legal responsibility claims; adjustments to relevant legal guidelines and laws, together with tax legal guidelines, world well being care reforms and import/export and commerce legal guidelines; tendencies towards well being care price containment; adjustments in habits and spending patterns of purchasers of well being care services; monetary instability of worldwide economies and authorized programs and sovereign threat; elevated scrutiny of the well being care business by authorities companies. An extra record and descriptions of those dangers, uncertainties and different components could be present in Johnson & Johnson’s Annual Report on Form 10-Okay for the fiscal 12 months ended January 2, 2022, together with in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” in Johnson & Johnson’s most just lately filed Quarterly Report on Form 10-Q and in Johnson & Johnson’s subsequent filings with the Securities and Exchange Commission. Copies of those filings can be found on-line at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Any forward-looking assertion made on this press launch speaks solely as of the date of this press launch. Johnson & Johnson doesn’t undertake to replace any forward-looking assertion as a results of new info or future occasions or developments.
View supply model on businesswire.com: https://www.businesswire.com/news/home/20220928005340/en/
